Continuing education needs of pediatricians across diverse specialties caring for children with medical complexity

Jori F Bogetz1, Alyssa L Bogetz2, Julia M Gabhart3

  • 1Lucile Packard Children's Hospital, Stanford University School of Medicine, Palo Alto, CA, USA jbogetz@stanford.edu.

Clinical Pediatrics
|January 7, 2015
PubMed

Insights

Pediatricians need more training to care for children with medical complexity (CMC). Integrating palliative care education can enhance skills in care coordination, communication, and goal setting for these children.

Area of Science:

  • Pediatric Healthcare
  • Medical Education
  • Palliative Care

Background:

  • Children with medical complexity (CMC) require specialized care.
  • Pediatricians often lack adequate preparation for managing CMC.
  • Tertiary academic centers are crucial for advanced pediatric care.

Purpose of the Study:

  • Assess continuing education needs of pediatricians for CMC care.
  • Identify specific skill gaps in managing CMC.
  • Inform curriculum development for pediatric residency and beyond.

Main Methods:

  • Online anonymous survey distributed to pediatricians at a US children's hospital.
  • Eighteen pediatricians from various subspecialties participated.
  • Modified grounded theory used for qualitative data analysis.

Main Results:

  • High response rate (89%) from diverse pediatric specialties.
  • Pediatricians identified needs in care coordination and goal setting.
  • Key skill deficits included communication (e.g., delivering bad news) and interprofessional teamwork.

Conclusions:

  • Pediatricians require enhanced skills for optimal CMC care.
  • Basic palliative care education is a potential solution for training gaps.
  • Targeted education can improve care coordination and patient-centered communication.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
391
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
886
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
929
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
371
Specialized Care Centers and Settings-II01:30

Specialized Care Centers and Settings-II

Rural Health Centers
Rural health centers are specialized care facilities in remote locations with very few medical personnel. The primary care providers who run the centers are mostly Registered Nurse Practitioners. Here, emergency treatment is provided to critically ill or injured patients before they are transferred to the closest hospital. Fortunately, due to advancement in technology, many rural healthcare facilities and professionals have easy access to diagnostic and treatment...
1.3K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
513